Talat Imran Rani Therapeutics Holdings, Inc. (RANI) insider trading activity

Talat Imran is Chief Executive Officer of Rani Therapeutics Holdings, Inc.. Currently has a direct ownership of 484,455 shares of RANI, which is worth approximately $1.84 Million. The most recent transaction as insider was on Dec 06, 2023, when has been sold 10,000 shares (Class A Common Stock) at a price of $2.27 per share, resulting in proceeds of $22,700. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 484K

0% 3M change

9.0% 12M change

Total Value Held $1.84 Million

Talat Imran Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 06 2023	BUY Open market or private purchase	$22,700 $2.27 p/Share	10,000 Added 2.02%	484,455 Class A Common Stock
Dec 04 2023	BUY Open market or private purchase	$12,850 $2.57 p/Share	5,000 Added 1.04%	474,455 Class A Common Stock
Nov 29 2023	BUY Open market or private purchase	$41,000 $2.05 p/Share	20,000 Added 4.09%	469,455 Class A Common Stock
Nov 07 2023	BUY Open market or private purchase	$10,000 $2.0 p/Share	5,000 Added 1.1%	449,455 Class A Common Stock
Mar 27 2023	BUY Grant, award, or other acquisition	-	353,500 Added 44.3%	444,445 Class A Common Stock
Mar 22 2023	SELL Payment of exercise price or tax liability	$47,528 $5.95 p/Share	7,988 Reduced 8.07%	90,945 Class A Common Stock
Mar 22 2022	BUY Grant, award, or other acquisition	-	86,600 Added 46.67%	98,943 Class A Common Stock

Talat Imran

Chief Executive Officer

San Jose, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RANI shares.

Notify only if

Value

Insider Trading

Get notified when an Rani Therapeutics Holdings, Inc. insider buys or sells RANI shares.

Notify only if

Operation

Value

Type

News

Receive news related to Rani Therapeutics Holdings, Inc.

Track Activities on RANI

Account